ArticlePloS one2025

Analytical validation of a hybrid-approach combining tumor-informed and tumor-agnostic bespoke ctDNA panel assay for the sensitive detection of minimal residual disease.

Sunghoon Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.